Vertigo Treatment Market Updates 2024 : Projected to Attain USD 1.9 Billion by 2031

Vertigo Treatment Market-Infographics-AMR

Vertigo Treatment Market

The growth in popularity of antihistamines for vertigo treatment are one of the factors that boosted the growth of the market.

Vertigo Treatment Market Size, Share, Competitive Landscape and Trend Analysis Report by Type, by Treatment, by Distribution channel : Global Opportunity Analysis and Industry Forecast, 2021-2031”
— Allied Market Research

WILMINGTON, DELAWARE , UNITED STATES, June 20, 2024 /EINPresswire.com/ -- According to a new report published by Allied Market Research, titled, “Vertigo Treatment Market," The vertigo treatment market size was valued at $1.3 billion in 2021, and is estimated to reach $1.9 billion by 2031, growing at a CAGR of 4.4% from 2022 to 2031.

Vertigo is a condition characterized by a sensation of whirling and a loss of balance. Symptoms of vertigo include nausea and vomiting, headache, tinnitus, motion sickness, and balance problems. It is important to note that vertigo is a symptom rather than a disorder, with at least 40% of adults experiencing vertigo at some point in their lives.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐭𝐨 𝐄𝐦𝐚𝐢𝐥 https://www.alliedmarketresearch.com/request-sample/A12485

Factors driving the growth of the global vertigo treatment market include the rising prevalence of central vertigo in developed countries such as the U.S. and Germany, the availability of medications for vertigo treatment, an increasing elderly population, and growing healthcare expenditure. Additionally, heightened awareness about inner ear problems and increased demand for vertigo treatment medications are expected to provide significant opportunities for market growth. For instance, according to the World Health Organization (WHO), the number of people aged over 60 years was 1 billion in 2019, and this number is projected to increase to 1.4 billion by 2030.

The global vertigo treatment market is segmented based on type, treatment, and distribution channel:

𝐁𝐲 𝐓𝐲𝐩𝐞:

Peripheral Vertigo: This segment dominated the market in terms of revenue and is the fastest-growing segment, with a CAGR of 4.7% from 2022 to 2031. This growth is attributed to the increasing prevalence of peripheral vertigo and the rising incidence of vertigo among adults.
Central Vertigo.

𝐁𝐲 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭:
Anticholinergics
Antihistamines: This segment exhibited the highest growth and is the fastest-growing segment, with a CAGR of 4.9% from 2022 to 2031. This growth is driven by the low cost of over-the-counter (OTC) medications and the increased use of antihistamines, which effectively treat nausea and vomiting.
Others (Antibiotics, Benzodiazepines, and Antidepressants)
By Distribution Channel:

Hospital Pharmacies
Drug Stores and Retail Pharmacies: This segment was the highest revenue contributor to the vertigo treatment market share in 2021. The market growth is driven by the increasing prevalence of central vertigo conditions and the development of new drugs for vertigo treatment by key industry players.
Online Providers: This segment is expected to exhibit the highest CAGR of 5.9% from 2022 to 2031, due to the increasing sales of antivertigo drugs through online pharmacies.

𝐒𝐩𝐞𝐚𝐤 𝐭𝐨 𝐎𝐮𝐫 𝐀𝐧𝐚𝐥𝐲𝐬𝐭 @ https://www.alliedmarketresearch.com/connect-to-analyst/A12485

𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘
Based on type, the peripheral vertigo segment held the largest market share in 2021 and is expected to remain dominant throughout the forecast period.
By treatment, the antihistamines segment held the largest market share in 2021 and is anticipated to continue this trend during the forecast period.
Based on distribution channel, the drug stores and retail pharmacies segment held the largest market share in 2021.
Based on region, North America is expected to experience largest growth in 2021, and registering a CAGR of 3.6% during the forecast period.

𝐊𝐞𝐲 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬 𝐅𝐨𝐫 𝐒𝐭𝐚𝐤𝐞𝐡𝐨𝐥𝐝𝐞𝐫𝐬
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the vertigo treatment market analysis from 2021 to 2031 to identify the prevailing vertigo treatment market opportunity.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the vertigo treatment market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global vertigo treatment market trends, key players, market segments, application areas, and market growth strategies.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-for-customization/A12485

𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐯𝐞𝐫𝐭𝐢𝐠𝐨 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐦𝐚𝐫𝐤𝐞𝐭
AstraZeneca Plc.
Endo Pharmaceuticals Inc.
Epic Pharma, LLC
GlaxoSmithKline Plc.
Hoffmann-La Roche
Novartis AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Ltd.
Viatris (Mylan N.V.)
Zydus Cadila

The report analyzes these key players in the global vertigo treatment market. These companies have adopted various strategies such as expansion, new product launches, partnerships, and other initiatives to increase their market penetration and strengthen their position in the industry. The report is helpful in determining each market player's business performance, operating segments, product portfolio, and developments.

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲:
𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐃𝐞𝐯𝐢𝐜𝐞 𝐀𝐟𝐟𝐚𝐢𝐫𝐬 𝐎𝐮𝐭𝐬𝐨𝐮𝐫𝐜𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/medical-device-affairs-outsourcing-market-A17667
𝐏𝐫𝐮𝐫𝐢𝐭𝐮𝐬 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/pruritus-therapeutics-market-A1752

David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.